Ankur Jain joins Whitehead Institute and the Department of Biology
Biophysicist will investigate the biology of RNA aggregation.
Biophysicist will investigate the biology of RNA aggregation.
Scientists leverage one step, unbiased method to characterize the binding preferences of more than 70 human RNA-binding proteins.
Scientists discover a pathway that monitors a protein import into mitochondria and elicits a cellular response when the process goes awry.
New discovery suggests that all life may share a common design principle.
Synthetic biologist hopes to develop treatments for cancer and other diseases.
New finding suggests differences in how humans and bacteria control production of DNA’s building blocks.
With SHERLOCK, a strip of paper can now indicate presence of pathogens, tumor DNA, or any genetic signature of interest.
Whitehead Institute researchers are using a modified CRISPR/Cas9-guided activation strategy to investigate the most frequent cause of intellectual disability in males.
Department of Biology kicks off IAP seminar series with a lecture by synthetic-biology visionary George Church.
Study explains why mutations that would seemingly affect all cells lead to face-specific birth defects.
Improved methods validate the use of blood samples for studying patients’ cancer genomes.
“REPAIR” system edits RNA, rather than DNA; has potential to treat diseases without permanently affecting the genome.
Advance may open new pathways for cancer immunotherapy.
Biological engineers identify genes that protect against protein linked to Parkinson’s disease.